Public-private partnerships in blindness prevention: reaching beyond the eye. (Q36320399)

13 August 2017

1 reference

title

Public-private partnerships in blindness prevention: reaching beyond the eye. (English)

1 reference

13 August 2017

Molyneux DH

1

1 reference

PubMed ID

16304584

13 August 2017

Nantulya V

series ordinal

2

1 reference

PubMed ID

16304584

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

19

1 reference

13 August 2017

10

1 reference

13 August 2017

1050-1056

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701961

13 August 2017

0 references

cites work

Partnership and promise: evolution of the African river-blindness campaigns

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Final report of the Conference on the eradicability of Onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Mectizan Donation Program: evaluation of a public-private partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Mass drug treatment for lymphatic filariasis and onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

The delivery of ivermectin (Mectizan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Ten years of NGDO action against river blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

The role of albendazole in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Community-perceived benefits of ivermectin treatment in northeastern Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

The Onchocerciasis Control Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Lymphatic filariasis: setting the scene for elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Lymphatic filariasis elimination: progress in global programme development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Worms: Identifying Impacts on Education and Health in the Presence of Treatment Externalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

Severe malaria attack is associated with high prevalence of Ascaris lumbricoides infection among children in rural Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

The public health importance of hookworm disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

inferred from DOI database lookup

7 January 2021

based on heuristic

Onchocerciasis control strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701961

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.EYE.6701961

1 reference

13 August 2017

1 reference

PubMed ID

16304584